Article Details
Retrieved on: 2018-03-04 23:02:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Last August, the company had already raised $30 million from investors including <b>Sequoia Capital</b> and Sofina SA. The Bengaluru-based firm would use the money to expand the clinical genomic testing market by penetrating all the Tier II and Tier III cities. The firm said it aims to democratize the critical ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here